Add BrightSurf on Google Email

Science News for March 14, 2003


Stem cells: From bone marrow to pancreas

Researchers successfully transplanted bone marrow cells from a male donor mouse to a female recipient, where they developed into functional insulin-expressing cells. The findings suggest that bone marrow may be a viable source for ex vivo expansion and autologous transplantation of pancreatic beta-cell precursors.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateMar 14, 2003

JCI Table of Contents, March 14, 2003

Research highlights the role of WNK kinases in regulating thiazide-sensitive Na-Cl cotransport, a key mechanism for maintaining electrolyte balance. Additionally, studies investigate the immunomodulatory effects of WNK kinases on pulmonary inflammation and diabetes, shedding light on potential therapeutic targets.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateMar 14, 2003

Bone marrow stem cells are a source of insulin-producing cells

Researchers have identified bone marrow stem cells with the ability to produce functional insulin-producing cells, offering a new potential avenue for treating diabetes. The study used a molecular biology technique called CRE-loxP to isolate and study these cells, which were found to exhibit characteristics of pancreatic beta cells.

SourceNYU Langone Health / NYU Grossman School of Medicine·JournalJournal of Clinical Investigation·DateMar 14, 2003

American Thoracic Society Journal news tips for March 2003 (second issue)

Two new studies report associations between prenatal exposure to maternal smoking and early-onset asthma with deficits in children's lung function. In the first study, a two-month rifampin/pyrazinamide regimen was found to be effective in treating latent TB in high-risk, non-adherent groups, but with potential liver toxicity risks.

SourceAmerican Thoracic Society·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateMar 14, 2003

Can vitamins slow the progression of Alzheimer’s disease?

A recent pilot study published in the American Journal of Geriatric Psychiatry found that high-dose vitamins can reduce homocysteine levels in individuals with mild to moderate Alzheimer's disease. The multicenter trial, known as Vital, aims to determine if these vitamins can slow the progression of the disease. Researchers are optimis...

SourceGeorgetown University Medical Center·JournalAmerican Journal of Geriatric Psychiatry·DateMar 14, 2003